What do you think of the relative success of Diabetic Retinopathy (DR) diagnostic models, especially the FDA approval of the clinical trials Digital Diagnostics (formerly IDxDR) [1]? Their approach to the model architecture was slightly different from the black-box approach of other labs, wherein IDxDR's model is trained to look for clinically relevant indicators for DR. Is that a more likely route for future diagnostic AI models?
[1]: https://dxs.ai/newsroom/pivotal-trial-results-behind-the-fda...